… case of Parkin) may be possible using nanoparticles to carry the gene of interest or therapeutic
… involved in the disease progression of PD and AD that may open the prospect of gene …

… Nanoparticles manufactured in the identical size range as … (PD) Parkinson's disease and
(AD) Alzheimer's disease are … also building new prospects for energy storage and harnessing. …

… Parkinson’s disease (PD) affects around ten million people worldwide and is considered
the second most prevalent neurodegenerative disease after Alzheimer’s disease. In addition, …

… Figure 3: Nanoparticles used in the treatment of Parkinson’s … nanoparticles in a
rotenone-induced chronic Parkinson … Parkinson disease and incidental Lewy body disease: Just a …

… Parkinson's disease (PD) is a debilitating neurological disorder characterized by the … to
impede disease advancement, and discuss the utilization of newly developed nanoparticles for …

… as recent approaches to treat the disease with nanoparticles. … like parkinson's disease
dementia and parkinson's disease-… These alterations are considered as a prospect to design an …

… available for the treatment of Parkinson's disease. However, the … nanocarriers in the treatment
of Parkinson's disease. … nanogel, micelles, and nanoparticles attract attention as a novel …

… nanoparticles [210,211]. Several studies have been published on the use of natural nanoparticles
with … for treating AD [212], rosemary acid for HD [213], curcumin for brain disease [214]. …

… EVs are membranous nanoparticles released in the extracellular space by almost all types
of cells, deriving from animals or plants, as well as produced by several microorganisms [27,…

… and treat Parkinson's disease. Improved diagnosis and treatment of Parkinson's disease can
help … They found that intravenous administration of nanoparticles decorated with lactoferrin …